enzyme linked immunosorbent assay elisa medium binding elisa microplates (Greiner Bio)
Greiner Bio is a verified supplier 
97
Structured Review
Greiner Bio
enzyme linked immunosorbent assay elisa medium binding elisa microplates
Enzyme Linked Immunosorbent Assay Elisa Medium Binding Elisa Microplates, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 97/100, based on 860 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/medium+binding+enzyme-linked+immunosorbent+assay+(elisa)+microplates/Microplate+96+Well+Ps+F-Bottom+Clear/pmc10694763__mmc3-254-14-22
Average 97 stars, based on 860 article reviews
Enzyme Linked Immunosorbent Assay Elisa Medium Binding Elisa Microplates, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 97/100, based on 860 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/medium+binding+enzyme-linked+immunosorbent+assay+(elisa)+microplates/Microplate+96+Well+Ps+F-Bottom+Clear/pmc10694763__mmc3-254-14-22
Average 97 stars, based on 860 article reviews
enzyme linked immunosorbent assay elisa medium binding elisa microplates - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Binding Assay:Article Title: An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2 Article Snippet: Stained cells were then washed with PBSA and acquired on an Attune NxT flow cytometer (Thermo Fisher Scientific). .. For YT-1 signaling studies on collagen-coated plates, medium binding Article Title: PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Article Snippet: Cell Reports Medicine 4, 101289, November 21, 2023 e4 Article ll OPEN ACCESS Collagen-binding enzyme-linked immunosorbent assay (ELISA) Medium binding ELISA microplates (Greiner Bio One) were coated with 100 mL of 10 mg/mL purified collagen I or III (Sigma-Aldrich) in 13 PBS for 1 h at 37 C. Wells were subsequently blocked with 200 mL of 2% BSA diluted in in PBS-T (0.5% Tween 20 in 13 PBS) at room temperature for 2 h followed by incubation at room temperature for 1 hwith 100 mL serial dilutions of IC in PBSA.Wells were then incubated for 1 h at room temperature with Peroxidase AffiniPure Goat Anti-Human IgG (H + L) (Jackson ImmunoResearch 115-035- 003; 1:10000) diluted in 100 mL PBSA followed by a 5-10-min room temperature incubation with 100 mL 1-Step Ultra TMB-ELISA Substrate Solution (Thermo Fisher Scientific) in the dark. .. Cell Reports Medicine 4, 101289, November 21, 2023 e4 Article ll OPEN ACCESS Collagen-binding Article Title: Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice. Article Snippet: SpikoGen® is a recombinant spike protein vaccine against COVID-19 that obtained marketing authorization in the Middle East on October 6th, 2021, becoming the first adjuvanted protein-based COVID-19 vaccine of its type to achieve approval.. SpikoGen® vaccine utilizes a unique adjuvant Advax-CpG55.2, which comprises delta inulin and CpG55.2 oligonucleotide, a synthetic human toll-like receptor (TLR)-9 agonist.. As part of a safety assessment, developmental and reproductive toxicity (DART) studies were undertaken in mice of Advax-CpG55.2 adjuvanted formulations including SpikoGen®, a H7 hemagglutinin influenza vaccine (rH7HA), the bivalent combination of SpikoGen® and rH7HA, and a next-generation quadrivalent spike protein vaccine. Article Title: An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2 Article Snippet: .. Enzyme-linked Immunosorbent Assay:Article Title: An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2 Article Snippet: Stained cells were then washed with PBSA and acquired on an Attune NxT flow cytometer (Thermo Fisher Scientific). .. For YT-1 signaling studies on collagen-coated plates, medium binding Article Title: PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Article Snippet: Cell Reports Medicine 4, 101289, November 21, 2023 e4 Article ll OPEN ACCESS Collagen-binding enzyme-linked immunosorbent assay (ELISA) Medium binding ELISA microplates (Greiner Bio One) were coated with 100 mL of 10 mg/mL purified collagen I or III (Sigma-Aldrich) in 13 PBS for 1 h at 37 C. Wells were subsequently blocked with 200 mL of 2% BSA diluted in in PBS-T (0.5% Tween 20 in 13 PBS) at room temperature for 2 h followed by incubation at room temperature for 1 hwith 100 mL serial dilutions of IC in PBSA.Wells were then incubated for 1 h at room temperature with Peroxidase AffiniPure Goat Anti-Human IgG (H + L) (Jackson ImmunoResearch 115-035- 003; 1:10000) diluted in 100 mL PBSA followed by a 5-10-min room temperature incubation with 100 mL 1-Step Ultra TMB-ELISA Substrate Solution (Thermo Fisher Scientific) in the dark. .. Cell Reports Medicine 4, 101289, November 21, 2023 e4 Article ll OPEN ACCESS Collagen-binding Article Title: Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice. Article Snippet: SpikoGen® is a recombinant spike protein vaccine against COVID-19 that obtained marketing authorization in the Middle East on October 6th, 2021, becoming the first adjuvanted protein-based COVID-19 vaccine of its type to achieve approval.. SpikoGen® vaccine utilizes a unique adjuvant Advax-CpG55.2, which comprises delta inulin and CpG55.2 oligonucleotide, a synthetic human toll-like receptor (TLR)-9 agonist.. As part of a safety assessment, developmental and reproductive toxicity (DART) studies were undertaken in mice of Advax-CpG55.2 adjuvanted formulations including SpikoGen®, a H7 hemagglutinin influenza vaccine (rH7HA), the bivalent combination of SpikoGen® and rH7HA, and a next-generation quadrivalent spike protein vaccine. Article Title: An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2 Article Snippet: .. Purification:Article Title: An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2 Article Snippet: Stained cells were then washed with PBSA and acquired on an Attune NxT flow cytometer (Thermo Fisher Scientific). .. For YT-1 signaling studies on collagen-coated plates, medium binding Article Title: PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Article Snippet: Cell Reports Medicine 4, 101289, November 21, 2023 e4 Article ll OPEN ACCESS Collagen-binding enzyme-linked immunosorbent assay (ELISA) Medium binding ELISA microplates (Greiner Bio One) were coated with 100 mL of 10 mg/mL purified collagen I or III (Sigma-Aldrich) in 13 PBS for 1 h at 37 C. Wells were subsequently blocked with 200 mL of 2% BSA diluted in in PBS-T (0.5% Tween 20 in 13 PBS) at room temperature for 2 h followed by incubation at room temperature for 1 hwith 100 mL serial dilutions of IC in PBSA.Wells were then incubated for 1 h at room temperature with Peroxidase AffiniPure Goat Anti-Human IgG (H + L) (Jackson ImmunoResearch 115-035- 003; 1:10000) diluted in 100 mL PBSA followed by a 5-10-min room temperature incubation with 100 mL 1-Step Ultra TMB-ELISA Substrate Solution (Thermo Fisher Scientific) in the dark. .. Cell Reports Medicine 4, 101289, November 21, 2023 e4 Article ll OPEN ACCESS Collagen-binding Article Title: An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2 Article Snippet: .. Control:Article Title: An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2 Article Snippet: Stained cells were then washed with PBSA and acquired on an Attune NxT flow cytometer (Thermo Fisher Scientific). .. For YT-1 signaling studies on collagen-coated plates, medium binding Incubation:Article Title: PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Article Snippet: Cell Reports Medicine 4, 101289, November 21, 2023 e4 Article ll OPEN ACCESS Collagen-binding enzyme-linked immunosorbent assay (ELISA) Medium binding ELISA microplates (Greiner Bio One) were coated with 100 mL of 10 mg/mL purified collagen I or III (Sigma-Aldrich) in 13 PBS for 1 h at 37 C. Wells were subsequently blocked with 200 mL of 2% BSA diluted in in PBS-T (0.5% Tween 20 in 13 PBS) at room temperature for 2 h followed by incubation at room temperature for 1 hwith 100 mL serial dilutions of IC in PBSA.Wells were then incubated for 1 h at room temperature with Peroxidase AffiniPure Goat Anti-Human IgG (H + L) (Jackson ImmunoResearch 115-035- 003; 1:10000) diluted in 100 mL PBSA followed by a 5-10-min room temperature incubation with 100 mL 1-Step Ultra TMB-ELISA Substrate Solution (Thermo Fisher Scientific) in the dark. .. Cell Reports Medicine 4, 101289, November 21, 2023 e4 Article ll OPEN ACCESS Collagen-binding Article Title: Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice. Article Snippet: SpikoGen® is a recombinant spike protein vaccine against COVID-19 that obtained marketing authorization in the Middle East on October 6th, 2021, becoming the first adjuvanted protein-based COVID-19 vaccine of its type to achieve approval.. SpikoGen® vaccine utilizes a unique adjuvant Advax-CpG55.2, which comprises delta inulin and CpG55.2 oligonucleotide, a synthetic human toll-like receptor (TLR)-9 agonist.. As part of a safety assessment, developmental and reproductive toxicity (DART) studies were undertaken in mice of Advax-CpG55.2 adjuvanted formulations including SpikoGen®, a H7 hemagglutinin influenza vaccine (rH7HA), the bivalent combination of SpikoGen® and rH7HA, and a next-generation quadrivalent spike protein vaccine. other:Article Title: Expression conditions and characterization of a novelly constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections. Article Snippet: |